New-onset bullous pemphigoid and flare of pre-existing bullous pemphigoid after the third dose of the COVID-19 vaccine

被引:6
|
作者
Bardazzi, Federico [1 ]
Carpanese, Miriam Anna [1 ]
Abbenante, Diego [1 ]
Filippi, Federica [1 ,2 ]
Sacchelli, Lidia [1 ]
Loi, Camilla [1 ]
机构
[1] IRCCS Azienda Osped Univ Bologna, Dermatol Unit, Bologna, Italy
[2] Univ Bologna, Dept Expt Diagnost & Specialty Med, Div Dermatol, Via Massarenti 1, I-40138 Bologna, Italy
关键词
D O I
10.1111/dth.15555
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [41] A Patient Develops Bullous Rash After Receiving the Second Dose of COVID-19 Vaccine
    Nida, Syeda S.
    Tobon, Gabriel J.
    Wilson, Morgan
    Chauhan, Krati
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (09)
  • [42] The risk of COVID-19 in patients with bullous pemphigoid and pemphigus: A population-based cohort study
    Kridin, Khalaf
    Schonmann, Yochai
    Weinstein, Orly
    Schmidt, Enno
    Ludwig, Ralf J.
    Cohen, Arnon D.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (01) : 79 - 87
  • [43] Severe bullous pemphigoid following Covid-19 vaccination resistant to rituximab and successfully treated with dupilumab
    Baffa, Maria E.
    Maglie, Roberto
    Montefusco, Francesca
    Pipito, Carlo
    Senatore, Stefano
    Antiga, Emiliano
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (02) : E135 - E137
  • [44] New-onset leukocytoclastic vasculitis after COVID-19 vaccine
    Bostan, Ecem
    Gulseren, Duygu
    Gokoz, Ozay
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2021, 60 (10) : 1305 - 1306
  • [45] Immunobullous diseases, prothrombotic state, and COVID-19: Role of prophylactic anticoagulation in bullous pemphigoid and pemphigus
    Anuragi, Ramesh Pratap
    Kansal, Naveen Kumar
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [46] Bullous pemphigoid with autoantibodies against full-length BP180 protein after COVID-19 infection
    Oya, Kazumasa
    Kakurai, Masakazu
    Izumi, Kentaro
    Ishii, Norito
    Nomura, Toshifumi
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (11) : E1266 - E1267
  • [47] Can Covid-19 vaccines cause or exacerbate bullous pemphigoid? A report of seven cases from one center
    Afacan, Elif
    Edek, Yusuf C.
    Ilter, Nilsel
    Gulekon, Ayla
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (05) : 626 - 627
  • [48] COVID-19 pandemic and autoimmune bullous diseases: a cross-sectional study of the International Pemphigus and Pemphigoid Foundation
    Kasperkiewicz, M.
    Yale, M.
    Strong, R.
    Zillikens, D.
    Woodley, D. T.
    Recke, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (07) : E418 - E421
  • [49] New-Onset Diabetes After COVID-19
    Kim, Sun H.
    Arora, Ipsa
    Hsia, Daniel S.
    Knowler, William C.
    LeBlanc, Erin
    Mylonakis, Eleftherios
    Pratley, Richard
    Pittas, Anastassios G.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (11): : E1164 - E1174
  • [50] New-onset severe headache after Covid-19 vaccine in Norway (CovaxHEAD)
    Argren, M. B.
    Lier, H.
    Boldingh, M.
    Devik, K.
    Gjendemsjo, K.
    Husoy, A.
    Mathisen, S. M.
    Morsund, A. H.
    Poole, A. C.
    Revheim, M. E.
    Schluter, K.
    Sonnervik, J.
    Skattor, T.
    Tronvik, E.
    Aalstad-Johansen, M.
    Toft, M.
    Winsvold, B. S.
    Aamodt, A. H.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25